LRG Webcast Series

Home/LRG Webcast Series
LRG Webcast Series2020-07-01T20:04:25-04:00

The Life Raft Group Webcast Series

The LRG produces several webcasts a year on various subjects focusing on GIST to educate and empower GIST patients. Check back often to see new webcasts that have been added and see our Events Calendar and our Facebook page for upcoming webcasts.

If you need more more information on LRG webcasts, please reach out to Sara Rothschild, Senior Vice President, Program Services at srothschild@liferaftgroup.org

LRG Webcast Series: GIST, TKI Treatment & Effects on Memory

May 15th, 2020|

This discussion reviewed CRCI in general, and how a person who is being treated for GIST could be affected. We also talked about strategies that can help ameliorate CRCI, new research on CRCI and GIST. we also gave advice on how cancer survivors can best cope with and care for themselves during this unusual global health event.

Conversations with the Life Raft Group LIVE

April 2nd, 2020|

Conversations with the Life Raft Group will debuted 4/2/2020 at 1 pm. Our first featured guest was Norman J. Scherzer, the Executive Director of the Life Raft Group. With his background at the CDC as Assistant Commissioner of Health for NYC, Norman is an excellent resource for discussing strategies for coping with COVID-19.

LRG Webcast Series: New Treatment Options for Advanced GIST & Concerns about the Coronavirus

March 24th, 2020|

During this webcast presentation, Dr. Michael Heinrich will discuss these two new treatment options for advanced GIST. Dr. Heinrich will explain how each of these drugs works to target mutations for which there has previously been no targeted treatment and discuss the current coronavirus outbreak.

LRG Webcast Series: When to Consider Surgery

August 14th, 2019|

Most GIST patients will see a surgeon at some point during their treatment. This webcast will address the issues surrounding the decision to have an operation and considers that surgical options depend on a number of factors such as tumor location, tumor size, tumor number, response to drug therapy, and risk of recurrence.

Core Values